Stimcell Energetics (STME) Gains from Investment Securities (2017 - 2025)
Stimcell Energetics' quarterly Gains from Investment Securities came in at $130000.0 in Q4 2025, up 8.33% quarter-over-quarter from $120000.0 in Q3 2025.
Stimcell Energetics has reported Gains from Investment Securities for 2 years, with the latest figure at $130000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to $130000.0; the trailing twelve-month figure through Feb 2026 stood at $357750.0 (changed N/A YoY), and the FY2025 full-year result was $107750.0, changed N/A from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $130000.0, up from $120000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $130000.0 in Q4 2025, with the low at $107750.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 130,000.00 |
| Nov 30, 2025 | 130,000.00 |
| Aug 31, 2025 | 120,000.00 |
| Aug 31, 2025 | 120,000.00 |
| May 31, 2025 | 107,750.00 |
| May 31, 2025 | 107,750.00 |
| Aug 31, 2017 | 522,407.00 |
| Aug 31, 2017 | 522,407.00 |